Targeting HSP90 in ovarian cancers with multiple receptor tyrosine kinase coactivation

<p>Abstract</p> <p>Background</p> <p>Ovarian cancer has the highest mortality rate of all gynecologic malignancy. The receptor tyrosine kinases (RTKs), including EGFR, ERBB2, PDGFR, VEGFR and MET, are activated in subsets of ovarian cancer, suggesting that these kinases might represent novel therape...

Cijeli opis

Bibliografski detalji

Glavni autori:	Zhou Haimeng, Meng Fanguo, Ou Wenbin, Jiao Yisheng, Wang Aiyuan
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2011-09-01
Serija:	Molecular Cancer
Teme:	Ovarian Cancer Tyrosine Kinases coactivation HSP90
Online pristup:	http://www.molecular-cancer.com/content/10/1/125
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!